About Tranexamic Acid

Therapeutic Category

Antifibrinolytic

Dose Form

Status

In Pipeline

Available Regulatory Filing

CAS No

1197-18-8

Pharmacopoeia

Mechanism of Action

Tranexamic acid is an antifibrinolytic agent that inhibits plasminogen activation, reducing the breakdown of fibrin clots. This action helps to control bleeding in various conditions, including heavy menstrual bleeding, surgical procedures, and trauma.

Indication

 Indicated for the treatment of excessive bleeding, including heavy menstrual bleeding and to reduce bleeding in certain surgical procedures.